Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma

Diseases of the Esophagus

Volumn 24, Issue 7, 2011, Pages 523-530

  Akagi, I ^a   Miyashita, M ^a   Ishibashi, O ^a   Mishima, T ^a   Kikuchi, K ^a   Makino, H ^a   Nomura, T ^a   Hagiwara, N ^a   Uchida, E ^a   Takizawa, T ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cancer; Esophagus; MicroRNA

Indexed keywords

DICER; DICER1; MESSENGER RNA; MICRORNA 21; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOGENESIS; CANCER RECURRENCE; CLINICAL FEATURE; CONTROLLED STUDY; DGCR8 RNA GENE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; GENE EXPRESSION; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIR143 RNA GENE; MIR144 RNA GENE; MIR145 RNA GENE; MIR205 RNA GENE; PRIORITY JOURNAL; RNA GENE; RNASEN RNA GENE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED;

EID: 80052971458     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01177.x     Document Type: Article

References (53)

1. Lin S L, Chang D, Wu D Y, Ying S Y. A novel RNA splicing-mediated gene silencing mechanism potential for genome evolution. Biochem Biophys Res Commun 2003; 310: 754-60.
2. Lee Y, Kim M, Han J etal. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23: 4051-60.
3. Lee Y, Ahn C, Han J etal. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003; 425: 415-9.
4. Denli A M, Tops B B, Plasterk R H, Ketting R F, Hannon G J. Processing of primary microRNAs by the Microprocessor complex. Nature 2004; 432: 231-5.
5. Gregory R I, Yan K P, Amuthan G etal. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004; 432: 235-40.
6. Yi R, Qin Y, Macara I G, Cullen B R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003; 17: 3011-6.
7. Lund E, Guttinger S, Calado A, Dahlberg J E, Kutay U. Nuclear export of microRNA precursors. Science 2004; 303: 95-8.
8. Ro S, Park C, Young D, Sanders K M, Yan W. Tissue-dependent paired expression of miRNAs. Nucleic Acids Res 2007; 35: 5944-53.
9. Schwarz D S, Hutvagner G, Du T, Xu Z, Aronin N, Zamore P D. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115: 199-208.
10. Khvorova A, Reynolds A, Jayasena S D. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003; 115: 209-16.
11. Lu J, Getz G, Miska E A etal. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-8.
12. Calin G A, Croce C M. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-66.
13. Michael M Z, SM O C, van Holst Pellekaan N G, Young G P, James R J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003; 1: 882-91.
14. Iorio M V, Ferracin M, Liu C G etal. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065-70.
15. Si M L, Zhu S, Wu H, Lu Z, Wu F, Mo Y Y. miR-21-mediated tumor growth. Oncogene 2007; 26: 2799-803.
16. Volinia S, Calin G A, Liu C G etal. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-61.
17. Ciafre S A, Galardi S, Mangiola A etal. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 2005; 334: 1351-8.
18. Zhu S, Si M L, Wu H, Mo Y Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007; 282: 14328-36.
19. Enzinger P C, Mayer R J. Esophageal cancer. N Engl J Med 2003; 349: 2241-52.
20. Guo Y, Chen Z, Zhang L etal. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008; 68: 26-33.
21. Dijckmeester W A, Wijnhoven B P, Watson D I etal. MicroRNA-143 and -205 expression in neosquamous esophageal epithelium following argon plasma ablation of Barrett's esophagus. J Gastrointest Surg 2009; 13: 846-53.
22. Jiang J, Lee E J, Gusev Y, Schmittgen T D. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res 2005; 33: 5394-403.
23. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N, Akao Y. Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology 2009; 77: 12-21.
24. Sugito N, Ishiguro H, Kuwabara Y etal. RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin Cancer Res 2006; 12: 7322-8.
25. Muralidhar B, Goldstein L D, Ng G etal. Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels. J Pathol 2007; 212: 368-77.
26. Zhang B, Pan X, Cobb G P, Anderson T A. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1-12.
27. Cheng Y, Ji R, Yue J etal. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol 2007; 170: 1831-40.
28. Ji R, Cheng Y, Yue J etal. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res 2007; 100: 1579-88.
29. Slaby O, Svoboda M, Fabian P etal. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007; 72: 397-402.
30. Chan J A, Krichevsky A M, Kosik K S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65: 6029-33.
31. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob S T, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-58.
32. Hiyoshi Y, Kamohara H, Karashima R etal. MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 2009; 15: 1915-22.
33. Corsten M F, Miranda R, Kasmieh R, Krichevsky A M, Weissleder R, Shah K. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 2007; 67: 8994-9000.
34. Asangani I A, Rasheed S A, Nikolova D A etal. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27: 2128-36.
35. Frankel L B, Christoffersen N R, Jacobsen A, Lindow M, Krogh A, Lund A H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008; 283: 1026-33.
36. Luo X, Chegini N. The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma. Semin Reprod Med 2008; 26: 500-14.
37. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo Y Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008; 18: 350-9.
38. Gottardo F, Liu C G, Ferracin M etal. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007; 25: 387-92.
39. Lebanony D, Benjamin H, Gilad S etal. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 2009; 27: 2030-7.
40. Kimura S, Naganuma S, Susuki D etal. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep 2010; 23: 1625-33.
41. Fletcher A M, Heaford A C, Trask D K. Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir-205. Transl Oncol 2008; 1: 202-8.
42. Neely L A, Rieger-Christ K M, Neto B S etal. A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol 2008; 28: 39-48.
43. Du Plessis L, Dietzsch E, Van Gele M etal. Mapping of novel regions of DNA gain and loss by comparative genomic hybridization in esophageal carcinoma in the black and colored populations of South Africa. Cancer Res 1999; 59: 1877-83.
44. Tada K, Oka M, Hayashi H, Tangoku A, Oga A, Sasaki K. Cytogenetic analysis of esophageal squamous cell carcinoma cell lines by comparative genomic hybridization: relationship of cytogenetic aberrations to in vitro cell growth. Cancer Genet Cytogenet 2000; 117: 108-12.
45. Yen C C, Chen Y J, Lu K H etal. Genotypic analysis of esophageal squamous cell carcinoma by molecular cytogenetics and real-time quantitative polymerase chain reaction. Int J Oncol 2003; 23: 871-81.
46. Kwong D, Lam A, Guan X etal. Chromosomal aberrations in esophageal squamous cell carcinoma among Chinese: gain of 12p predicts poor prognosis after surgery. Hum Pathol 2004; 35: 309-16.
47. Scotto L, Narayan G, Nandula S V etal. Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha. Mol Cancer 2008; 7: 58.
48. Davis B N, Hilyard A C, Lagna G, Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008; 454: 56-61.
49. Akagi I, Miyashita M, Makino H etal. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma. Ann Surg Oncol 2008; 15: 2965-75.
50. Fu Y F, Du T T, Dong M etal. Mir-144 selectively regulates embryonic {alpha}-hemoglobin synthesis during primitive erythropoiesis. Blood 2008; 116: 4338-48.
51. Zhang X, Liu S, Hu T, Liu S, He Y, Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 2009; 50: 490-9.
52. He L, Thomson J M, Hemann M T etal. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-33.
53. O'Donnell K A, Wentzel E A, Zeller K I, Dang C V, Mendell J T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839-43.